CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)	12 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flows from operating activities:
Net loss	$ (10,515,124)	$ (7,909,600)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	367,556	371,914
Fair value of vested options issued to officers, directors and employees	1,485,068	2,545,305
Amortization of capitalized financing costs	858,985	331,665
Amortization of debt discount attributable to convertible debentures	2,096,427	512,530
Equity based compensation	1,444,583	1,250,951
Common stock issued in settlement of interest	36,997	195,794
Fair value change from employee option modifications	738,810
Change in assets and liabilities:
Increase in accounts receivable	(145,558)	(15,727)
Decrease in prepaid expenses and deposits	70,030	31,865
(Decrease) increase in accounts payable and accrued liabilities	(199,490)	230,114
Net cash used in operating activities	(3,761,716)	(2,455,189)
Cash flows from investing activities:
Purchase of property and equipment	(89,108)
Net cash used in investing activities	(89,108)
Cash flows from financing activities:
Net proceeds from (repayments of) related party advances	(50,000)	50,000
Net proceeds from sale of common stock	4,735,000
Net proceeds from issuance of convertible notes	1,895,500	2,209,500
Net cash provided by financing activities	6,580,500	2,259,500
Net increase (decrease) in cash and cash equivalents	2,729,676	(195,689)
Cash and cash equivalents at beginning of year	17,618	213,307
Cash and cash equivalents at end of year	2,747,294	17,618
Supplemental Disclosures of Cash Flow Information:
Cash paid during the year for interest
Cash paid during the year for taxes
Non-cash transactions:
Fair value of warrants issued for financing costs	217,971
Common stock issued in exchange for previously incurred debt	$ 409,997	$ 3,031,849